Davis Todd C - Insider Transactions
Insider Type
individual
Companies
1
Average
320,628
Total Txns
7
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2024 | 1 | 0 | 1 | 243,480.50 | 0.00 | 243,480.50 |
| 2025 | 6 | 0 | 6 | 2,000,912.76 | 0.00 | 2,000,912.76 |
| Total: | 7 | 0 | 7 | 2,244,393.26 | 0.00 | 2,244,393.26 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Ligand Pharmaceuticals Incorporated Tr Beta Continngent Value Right |
104.57 USD |
1,680 Bought |
175,678 USD |
09/05/2025 | 09/05/2025 |
| Ligand Pharmaceuticals Incorporated Tr Beta Continngent Value Right |
104.53 USD |
2,307 Bought |
241,150 USD |
09/05/2025 | 09/05/2025 |
| Ligand Pharmaceuticals Incorporated Tr Beta Continngent Value Right |
105.67 USD |
5,523 Bought |
583,629 USD |
09/05/2025 | 09/05/2025 |
| Ligand Pharmaceuticals Incorporated Tr Beta Continngent Value Right |
104.57 USD |
1,680 Bought |
175,678 USD |
09/05/2025 | 09/05/2025 |
| Ligand Pharmaceuticals Incorporated Tr Beta Continngent Value Right |
104.53 USD |
2,307 Bought |
241,150 USD |
09/05/2025 | 09/05/2025 |
| Ligand Pharmaceuticals Incorporated Tr Beta Continngent Value Right |
105.67 USD |
5,523 Bought |
583,629 USD |
09/05/2025 | 09/05/2025 |
| Ligand Pharmaceuticals Incorporated Tr Beta Continngent Value Right |
97.39 USD |
2,500 Bought |
243,481 USD |
08/08/2024 | 08/08/2024 |